GLP_1 RA Ultrasound Study
Part of paid clinical trials in Cincinnati, Ohio.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT06581120
- Status
- Enrolling By Invitation
Conditions
- Delayed Gastric Emptying
- Diabetes
- Glucagon Like Peptide-1 (GLP-1
- Morbid Obesity
- Risk of Aspiration
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 25 Years
- Healthy Volunteers
- Accepted
Interventions
- Glucagon-Like Peptide-1 receptor agonists — DRUGGLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs.
- Point of Care Gastric Ultrasound — DIAGNOSTIC_TESTA gastric ultrasound following a standard NPO period to determine gastric contents and risk of aspiration during surgery.
Study Details
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
Key Dates
- Start date
- Jul 8, 2024
- Status verified
- Nov 2024
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: GLP-1Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.
- Arm: ControlIndividuals not taking GLP-1 who have a surgery scheduled with Cincinnati Children's Hospital same day surgery or endocrinology clinic and will receive a point of care gastric ultrasound.
Primary Outcome Measure
Aspiration Risk determined by POGUS [ Time Frame: Two years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45299 | - |
Find similar trials in Cincinnati, OH
By research site
Related Studies
- Exciflex for Chronic Wound TherapyRecruiting · VA Office of Research and Development · Cleveland, Ohio
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesRecruiting · Endogenex, Inc. · Birmingham, Alabama
- Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)Recruiting · Salvador Navarrete · Cleveland, Ohio
- Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal ClientsRecruiting · Ohio State University · Columbus, Ohio